Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Crinetics Pharmaceuticals, Inc. (CRNX) had Free Cash Flow per Share of $-2.84 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.00M |
|
$-80.59M |
|
-- |
|
$0.00M |
|
$94.75M |
|
$-94.75M |
|
$14.15M |
|
$-80.59M |
|
$-80.59M |
|
$-80.59M |
|
$-80.59M |
|
$-80.59M |
|
$-80.59M |
|
$-94.75M |
|
$-98.12M |
|
80.78M |
|
80.78M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$1.38B |
|
$12.07M |
|
$59.20M |
|
$1.43B |
|
$59.68M |
|
-- |
|
$50.10M |
|
$109.79M |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
92.93M |
|
| Cash Flow Statement Financials | |
$-225.97M |
|
$-574.82M |
|
$1.01B |
|
$56.20M |
|
$265.85M |
|
$209.65M |
|
$69.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-229.81M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-6.08% |
|
-6.08% |
|
-5.62% |
|
-6.08% |
|
$14.26 |
|
|
Free Cash Flow per Share |
$-2.84 |
$-2.80 |
|